Published by
@ShahidNShah
@ShahidNShah
Measuring What Matters in Diabetes
This Viewpoint discusses the inadequacy of hemoglobin A1c levels as a marker of effects of treatment on clinically important diabetes outcomes, and argues for replacing it with measures of treatment effects important to patients and their caregivers, such as hyperglycemia and hypoglycemia, vision…
Continue reading at jamanetwork.com
Make faster decisions with community advice
- Scientists rise up against statistical significance
- ONC: Here’s how hospitals are using EHR data beyond patient care
- 3 questions to ask before putting a healthcare application in the cloud
- Venrock: AI finding its place, blockchain may never matter
- Survey: Telehealth adoption, interest increased 340% among physicians since 2015
Next Article
-
Scientists rise up against statistical significance
Valentin Amrhein, Sander Greenland, Blake McShane and more than 800 signatories call for an end to hyped claims and the dismissal of possibly crucial effects.
Posted Apr 21, 2019
